dimyristoylphosphatidylcholine has been researched along with Cystic Fibrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aikawa, M; Fox, B; Fox, E; Gorman, CM; Lapuz, C; Michaud, B; Nguyen, H; Roche, E; Sawa, T; Wiener-Kronish, JP | 1 |
| Alton, E; Geddes, D; Gill, D; Greening, A; Higgins, C; Hyde, S; Innes, JA; Porteous, D; Stern, M | 1 |
2 other study(ies) available for dimyristoylphosphatidylcholine and Cystic Fibrosis
| Article | Year |
|---|---|
Efficient in vivo delivery of DNA to pulmonary cells using the novel lipid EDMPC.
Topics: Animals; Cell Line; Chloramphenicol O-Acetyltransferase; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Dimyristoylphosphatidylcholine; DNA; Female; Gene Expression; Gene Transfer Techniques; Genetic Markers; Genetic Therapy; Immunohistochemistry; Liposomes; Lung; Mice; Phosphatidylethanolamines; Rats; Rats, Sprague-Dawley | 1997 |
Measure and interpretation of CF gene therapy trial results.
Topics: Chlorides; Clinical Trials as Topic; Cystic Fibrosis; Dimyristoylphosphatidylcholine; Genetic Therapy; Genetic Vectors; Humans; Liposomes; Nasal Mucosa; Research Design | 2000 |